Interim subgroup analysis for response by PD-L1 status of CLASSICAL-Lung, a phase Ib/II study of pepinemab (VX15/2503) in combination with avelumab in advanced NSCLC
Shafique, Michael Rahman, Fisher, Terrence Lee, Evans, Elizabeth E., Leonard, John E., Pastore, Desa Rae Electa, Mallow, Crystal L., Smith, Ernest, Schröder, Andreas, Chin, Kevin M., Beck, Joseph Thaddeus, Baumgart, Megan Ann, Govindan, Ramaswamy, Gabrail, Nashat Y., Sanborn, Rachel E., Spira, Alexander I., Seetharamu, Nagashree, Lou, Yanyan, Mansfield, Aaron Scott, Goldman, Jonathan Wade, Zauderer, Maurice
Published in Journal of clinical oncology (20.05.2020)
Published in Journal of clinical oncology (20.05.2020)
Get full text
Journal Article
Evidence that semaphorin 4D is upregulated in neurons in Huntington’s and Alzheimer’s diseases: Effects of a SEMA4D blocking antibody on FDG‐PET in a clinical trial, and treatment rationale for its use in AD
Evans, Elizabeth E., Fisher, Terrence L., Leonard, John E., Reader, Alisha M., Mishra, Vikas, Mallow, Crystal L., Balch, Leslie, Howell, Alan, Smith, Ernest S., Feigin, Andrew, Siemers, Eric R., Zauderer, Maurice
Published in Alzheimer's & dementia (01.12.2020)
Published in Alzheimer's & dementia (01.12.2020)
Get full text
Journal Article
Evidence that semaphorin 4D is upregulated in neurons in Huntington’s and Alzheimer’s diseases: Effects of a SEMA4D blocking antibody on FDG‐PET in a clinical trial, and treatment rationale for its use in AD: Human/Human trials: Other
Evans, Elizabeth E., Fisher, Terrence L., Leonard, John E., Reader, Alisha M., Mishra, Vikas, Mallow, Crystal L., Balch, Leslie, Howell, Alan, Smith, Ernest S., Feigin, Andrew, Siemers, Eric R., Zauderer, Maurice
Published in Alzheimer's & dementia (01.12.2020)
Published in Alzheimer's & dementia (01.12.2020)
Get full text
Journal Article
Interim results from a phase Ib/II study of pepinemab in combination with avelumab in advanced NSCLC patients following progression on prior systemic and/or anti-PDx therapies
Shafique, Michael Rahman, Fisher, Terrence Lee, Evans, Elizabeth E., Leonard, John E., Pastore, Desa Rae Electa, Mallow, Crystal L., Smith, Ernest, Schröder, Andreas, Chin, Kevin M., Beck, J. Thaddeus, Baumgart, Megan Ann, Govindan, Ramaswamy, Gabrail, Nashat Y., Sanborn, Rachel E., Spira, Alexander I., Seetharamu, Nagashree, Lou, Yanyan, Mansfield, Aaron Scott, Goldman, Jonathan Wade, Zauderer, Maurice
Published in Journal of clinical oncology (10.02.2020)
Published in Journal of clinical oncology (10.02.2020)
Get full text
Journal Article
VX15 ANTI-SEMAPHORIN 4D ANTIBODY (PEPINEMAB) INCREASES FDG-PET SIGNAL AND IS A POTENTIAL TREATMENT FOR ALZHEIMER’S DISEASE
Fisher, Terrence L., Evans, Elizabeth E., Leonard, John E., Reader, Alisha M., Mallow, Crystal L., Balch, Leslie, Howell, Alan, Smith, Ernest S., Zauderer, Maurice, Feigin, Andrew
Published in Alzheimer's & dementia (01.07.2019)
Published in Alzheimer's & dementia (01.07.2019)
Get full text
Journal Article
P3‐007: VX15 ANTI‐SEMAPHORIN 4D ANTIBODY (PEPINEMAB) INCREASES FDG‐PET SIGNAL AND IS A POTENTIAL TREATMENT FOR ALZHEIMER'S DISEASE
Fisher, Terrence L., Evans, Elizabeth E., Leonard, John E., Reader, Alisha M., Mallow, Crystal L., Balch, Leslie, Howell, Alan, Smith, Ernest S., Zauderer, Maurice, Feigin, Andrew
Published in Alzheimer's & dementia (01.07.2019)
Published in Alzheimer's & dementia (01.07.2019)
Get full text
Journal Article
Abstract 1545: Altered myeloid and lymphoid composition of tumor microenvironment following anti-SEMA4D and immune checkpoint combination therapies
Evans, Elizabeth E., Fisher, Terrence L., Bussler, Holm, Mallow, Crystal, Reilly, Christine, Torno, Sebold, Pastore, Desa Rae, Scrivens, Maria, Howell, Alan, Balch, Leslie, Leonard, John E., Allen, Clint, Clavijo, Paul E., Lesinski, Gregory, Wu, Christina, Steuer, Conor, Saba, Nabil F., Olson, Brian, Hu-Lieskovan, Siwen, Ribas, Antoni, Greengard, Emily G., Smith, Ernest S., Zauderer, Maurice
Published in Cancer research (Chicago, Ill.) (01.07.2019)
Published in Cancer research (Chicago, Ill.) (01.07.2019)
Get full text
Journal Article
Preliminary results from CLASSICAL-Lung, a phase 1b/2 study of pepinemab (VX15/2503) in combination with avelumab in advanced NSCLC
Shafique, Michael Rahman, Fisher, Terrence Lee, Evans, Elizabeth E., Leonard, John E., Pastore, Desa Rae Electa, Mallow, Crystal L., Smith, Ernest, Zauderer, Maurice, Schröder, Andreas, Chin, Kevin M., Beck, J. Thaddeus, Baumgart, Megan Ann, Govindan, Ramaswamy, Sanborn, Rachel E., Goldman, Jonathan Wade
Published in Journal of clinical oncology (20.05.2019)
Published in Journal of clinical oncology (20.05.2019)
Get full text
Journal Article
Preventing Avoidable Rehospitalizations through Standardizing Management of Chronic Conditions in Skilled Nursing Facilities
Hsiao, Ya Luan, Bass, Eric B, Wu, Albert W, Kelly, Denise, Sylvester, Carol, Berkowitz, Scott A, Bellantoni, Michele
Published in Journal of the American Medical Directors Association (01.12.2023)
Published in Journal of the American Medical Directors Association (01.12.2023)
Get more information
Journal Article
Multidrug Resistance Among Streptococcus pneumoniae Isolated at a University Hospital in Eastern Tennessee
Get full text
Journal Article
Conference Proceeding
Preparation of surface-functionalized electrospun PVA nanowebs for potential remedy for SARS-CoV-2
Ayodeji, Olukayode J., Khyum, Mirza M.O., Afolabi, Racheal T., Smith, Ernest, Kendall, Ron, Ramkumar, Seshadri
Published in Journal of hazardous materials advances (01.08.2022)
Published in Journal of hazardous materials advances (01.08.2022)
Get full text
Journal Article
Genotypic variation in aluminum resistance, cellular aluminum fractions, callose and pectin formation and organic acid accumulation in roots of Populus hybrids
Smith, Ernest, Naik, Dhiraj, Cumming, Jonathan R.
Published in Environmental and experimental botany (01.09.2011)
Published in Environmental and experimental botany (01.09.2011)
Get full text
Journal Article
Abstract B199: Targeting the tumor microenvironment with first-in-class Semaphorin4D MAb for combination immunotherapy
Evans, Elizabeth E., Bussler, Holm, Mallow, Crystal, Reilly, Christine, Torno, Sebold, Scrivens, Maria, Foster, Cathie, Howell, Alan, Balch, Leslie, Leonard, John E., Fisher, Terrence L., Allen, Clint, Clavijo, Paul, Hu-Lieskovan, Siwen, Ribas, Antoni, Smith, Ernest S., Zauderer, Maurice
Published in Molecular cancer therapeutics (01.01.2018)
Published in Molecular cancer therapeutics (01.01.2018)
Get full text
Journal Article
Abstract 3661: Breaking down the barrier restricting infiltration and differentiation of APC in the tumor microenvironment with a first-in-class antibody targeting Semaphorin4D, and rational combination therapies
Evans, Elizabeth E., Bussler, Holm, Mallow, Crystal, Reilly, Christine, Torno, Sebold, Scrivens, Maria, Foster, Cathie, Howell, Alan, Comeau, Stephen R., Balch, Leslie, Knapp, Alyssa, Leonard, John E., Fisher, Terrence L., Hu-Lieskovan, Siwen, Ribas, Antoni, Smith, Ernest S., Zauderer, Maurice
Published in Cancer research (Chicago, Ill.) (01.07.2017)
Published in Cancer research (Chicago, Ill.) (01.07.2017)
Get full text
Journal Article
Abstract 1762: Shifting the tumor microenvironment with first-in-class semaphorin 4D mab for combination immunotherapy
Evans, Elizabeth E., Bussler, Holm, Mallow, Crystal, Reilly, Christine, Torno, Sebold, Scrivens, Maria, Howell, Alan, Balch, Leslie, Leonard, John E., Fisher, Terrence, Allen, Clint, Clavijo, Paul E., Lesinski, Gregory, Wu, Christina, Hu-Lieskovan, Siwen, Ribas, Antoni, Greengard, Emily G., Smith, Ernest S., Zauderer, Maurice
Published in Cancer research (Chicago, Ill.) (01.07.2018)
Published in Cancer research (Chicago, Ill.) (01.07.2018)
Get full text
Journal Article
항-CCR8 항체 및 이의 용도
HARVEY CARRIE, HOLLAND PAMELA M, SMITH ERNEST, SCRIVENS MARIA, KIRK RENEE, LAKE ANDREW, BALCH LESLIE, DULAK AUSTIN, DAS SONIA G, WELLS CHRISTOPHER CONVERSE
Year of Publication 02.09.2022
Get full text
Year of Publication 02.09.2022
Patent
Abstract CT111: Phase 1/2 study of pepinemab, an inhibitor of semaphorin 4D, in combination with pembrolizumab as first-line treatment of recurrent or metastatic head and neck cancer (KEYNOTE B84)
Fisher, Terrence L., Evans, Elizabeth E., Mallow, Crystal, Foster, Amber, Boise, Megan, Smith, Ernest, Leonard, John E., Chaney, Marya F., Beck, J. Thaddeus, Hager, Steven, Saba, Nabil F., Steuer, Conor, Adkins, Douglas, Burtness, Barbara, Zauderer, Maurice
Published in Cancer research (Chicago, Ill.) (15.06.2022)
Published in Cancer research (Chicago, Ill.) (15.06.2022)
Get full text
Journal Article